Manulife (Manufacturers Life Insurance)
EWTX icon

Manulife (Manufacturers Life Insurance)’s Edgewise Therapeutics EWTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
40,757
+5,307
+15% +$183K ﹤0.01% 1690
2026
Q1 		$1.12M Sell
35,450
-1,309
-4% -$37.7K ﹤0.01% 1775
2025
Q4 		$912K Buy
36,759
+1,221
+3% +$24.5K ﹤0.01% 1895
2025
Q3 		$576K Sell
35,538
-2,790
-7% -$39.6K ﹤0.01% 2149
2025
Q2 		$502K Sell
38,328
-18,660
-33% -$269K ﹤0.01% 2176
2025
Q1 		$1.25M Buy
56,988
+16,818
+42% +$441K ﹤0.01% 1702
2024
Q4 		$1.07M Buy
40,170
+1,760
+5% +$56K ﹤0.01% 1879
2024
Q3 		$1.03M Buy
38,410
+44
+0.1% +$875 ﹤0.01% 1916
2024
Q2 		$691K Buy
38,366
+7,786
+25% +$136K ﹤0.01% 2054
2024
Q1 		$558K Buy
30,580
+13,322
+77% +$212K ﹤0.01% 2163
2023
Q4 		$189K Sell
17,258
-662
-4% -$4.65K ﹤0.01% 2644
2023
Q3 		$103K Buy
17,920
+192
+1% +$1.3K ﹤0.01% 2797
2023
Q2 		$137K Buy
17,728
+3,294
+23% +$27.8K ﹤0.01% 2739
2023
Q1 		$96.3K Hold
14,434
– – ﹤0.01% 2751
2022
Q4 		$129K Buy
14,434
+1,827
+14% +$17.1K ﹤0.01% 2726
2022
Q3 		$124K Sell
12,607
-410
-3% -$4.14K ﹤0.01% 2749
2022
Q2 		$104K Sell
13,017
-2,713
-17% -$20.5K ﹤0.01% 2896
2022
Q1 		$153K Sell
15,730
-3,204
-17% -$41.2K ﹤0.01% 2860
2021
Q4 		$289 Buy
+18,934
New +$341K ﹤0.01% 2622

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Manulife (Manufacturers Life Insurance)'s EWTX Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Edgewise Therapeutics (EWTX) stake by 15% in Q2 2026, buying an estimated $183K and bringing the position to 40,757 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1690.

Manulife (Manufacturers Life Insurance) first reported a position in EWTX in Q4 2021 and has held it in 19 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 40,757 shares of Edgewise Therapeutics worth $1.66M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 5,307 Edgewise Therapeutics shares in Q2 2026, an estimated $183K.
  • Edgewise Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1690 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Edgewise Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.